Connor, Clark & Lunn Investment Management (CC&L)’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-111,173
| Closed | -$54K | – | 1143 |
|
|
2020
Q4 | $54K | Sell |
111,173
-10,070
| -8% | -$4.89K | ﹤0.01% | 875 |
|
|
2020
Q3 | $66K | Sell |
121,243
-14,754
| -11% | -$8.03K | ﹤0.01% | 890 |
|
|
2020
Q2 | $94K | Sell |
135,997
-62,661
| -32% | -$43.3K | ﹤0.01% | 957 |
|
|
2020
Q1 | $167K | Buy |
198,658
+25,586
| +15% | +$21.5K | ﹤0.01% | 886 |
|
|
2019
Q4 | $284K | Buy |
173,072
+12,350
| +8% | +$20.3K | ﹤0.01% | 772 |
|
|
2019
Q3 | $178K | Buy |
160,722
+4,643
| +3% | +$5.14K | ﹤0.01% | 879 |
|
|
2019
Q2 | $194K | Buy |
156,079
+6,874
| +5% | +$8.54K | ﹤0.01% | 905 |
|
|
2019
Q1 | $215K | Sell |
149,205
-13,100
| -8% | -$18.9K | ﹤0.01% | 813 |
|
|
2018
Q4 | $192K | Buy |
162,305
+17,202
| +12% | +$20.3K | ﹤0.01% | 856 |
|
|
2018
Q3 | $196K | Buy |
145,103
+129,228
| +814% | +$175K | ﹤0.01% | 851 |
|
|
2018
Q2 | $36K | Buy |
+15,875
| New | +$36K | ﹤0.01% | 1016 |
|
|
2016
Q1 | – | Sell |
-26,800
| Closed | -$93K | – | 929 |
|
|
2015
Q4 | $93K | Sell |
26,800
-4,400
| -14% | -$15.3K | ﹤0.01% | 762 |
|
|
2015
Q3 | $191K | Buy |
+31,200
| New | +$191K | ﹤0.01% | 646 |
|